95
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Predictors Of Postoperative Lower Urinary Tract Symptoms Improvements In Patient With Small-Volume Prostate And Bladder Outlet Obstruction

, , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1291-1304 | Published online: 07 Nov 2019

References

  • Ke ZB, Cai H, Wu YP, et al. Identification of key genes and pathways in benign prostatic hyperplasia. J Cell Physiol. 2019;234(11):19942–19950. doi:10.1002/jcp.2859231187492
  • Kang M, Kim M, Choo MS, Paick JS, Oh SJ. Urodynamic features and significant predictors of bladder outlet obstruction in patients with lower urinary tract symptoms/benign prostatic hyperplasia and small prostate volume. Urology. 2016;89:96–102. doi:10.1016/j.urology.2015.11.02726683755
  • Hashimoto M, Shimizu N, Sugimoto K, et al. Efficacy of adding dutasteride to alpha-blocker therapy treated benign prostatic hyperplasia patients with small volume prostate (<30 mL). Low Urin Tract Symptoms. 2017;9(3):157–160. doi:10.1111/luts.1212726991643
  • Cao JJ, Huang W, Wu HS, et al. Prostatic calculi: do they matter? Sex Med Rev. 2018;6(3):482–491. doi:10.1016/j.sxmr.2017.10.00329157875
  • Guneyli S, Ward E, Thomas S, et al. Magnetic resonance imaging of benign prostatic hyperplasia. Diagn Interv Radiol. 2016;22(3):215–219. doi:10.5152/dir27015442
  • Kang DH, Lee JY, Hah YS, et al. Correlation of prostatic urethral angle with the severity of urinary symptom and peak flow rate in men with small prostate volume. PLoS One. 2014;9(8):e104395. doi:10.1371/journal.pone.010439525127394
  • Singh K, Sinha RJ, Sokhal A, Singh V. Does prostate size predict the urodynamic characteristics and clinical outcomes in benign prostate hyperplasia? Urol Ann. 2017;9(3):223–229. doi:10.4103/0974-7796.21002928794586
  • Xu N, Chen SH, Xue XY, et al. Older age and larger prostate volume are associated with stress urinary incontinence after plasmakinetic enucleation of the prostate. Biomed Res Int. 2017;2017:6923290. doi:10.1155/2017/692329028466017
  • Kuei CH, Liao CH, Chiang BJ. Significant intravesical prostatic protrusion and prostatic calcification predict unfavorable outcomes of medical treatment for male lower urinary tract symptoms. Urol Sci. 2016;27(1):13–16. doi:10.1016/j.urols.2015.01.003
  • Zhang J, Li X, Yang B, et al. Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. World J Urol. 2019;37(1):143–153. doi:10.1007/s00345-018-2370-z29948047
  • Park B, Choo SH. The burden of prostatic calculi is more important than the presence. Asian J Androl. 2017;19(4):482–485. doi:10.4103/1008-682X.18119327184549
  • Suh YS, Ko KJ, Kim TH, Sung HH, Lee KS. Efficacy of holmium laser transurethral incision of the prostate in symptomatic mild-to-moderate benign prostate enlargement based on preoperative characteristics. Low Urin Tract Symptoms. 2018;10(3):231–236. doi:10.1111/luts.1216828436120
  • Han JH, Kwon JK, Lee JY, et al. Is periurethral calcification associated with urinary flow rate and symptom severity in men with lower urinary tract symptoms-benign prostatic hyperplasia? A retrospective review. Urology. 2015;85(5):1156–1161. doi:10.1016/j.urology.2015.01.03825818911
  • Yang HJ, Huang KH, Wang CW, Chang HC, Yang TK. Prostate calcification worsen lower urinary tract symptoms in middle-aged men. Urology. 2013;81(6):1320–1324. doi:10.1016/j.urology.2013.02.02123561714
  • Luo YH, Shen JH, Guan RY, Li H, Wang J. Plasmakinetic enucleation of the prostate vs plasmakinetic resection of the prostate for benign prostatic hyperplasia: comparison of outcomes according to prostate size in 310 patients. Urology. 2014;84(4):904–910. doi:10.1016/j.urology.2014.06.02525150180
  • Braeckman J, Denis L. Management of BPH then 2000 and now 2016 - From BPH to BPO. Asian J Urol. 2017;4(3):138–147. doi:10.1016/j.ajur.2017.02.00229264222
  • Cumpanas AA, Botoca M, Minciu R, Bucuras V. Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin. Urology. 2013;81(4):859–863. doi:10.1016/j.urology.2012.12.00723375910
  • Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67(6):1099–1109. doi:10.1016/j.eururo.2014.12.03825613154
  • Lee JW, Ryu JH, Yoo TK, et al. Relationship between intravesical prostatic protrusion and postoperative outcomes in patients with benign prostatic hyperplasia. Korean J Urol. 2012;53(7):478–482. doi:10.4111/kju.2012.53.7.47822866219
  • Han JH, Lee JY, Kwon JK, Lee JS, Cho KS. Clinical significance of periurethral calcification according to the location in men with lower urinary tract symptoms and a small prostate volume. Int Neurourol J. 2017;21(3):220–228. doi:10.5213/inj.1732732.36628954459
  • Samir M, Tawfick A, Mahmoud MA, et al. Two-year follow-up in bipolar transurethral enucleation and resection of the prostate in comparison with bipolar transurethral resection of the prostate in treatment of large prostates. Randomized controlled trial. Urology. 2019. doi:10.1016/j.urology.2019.07.029
  • Wei Y, Xu N, Chen SH, et al. Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: a retrospective study at a single academic tertiary care center. Int Braz J Urol. 2016;42(4):747–756. doi:10.1590/S1677-5538.IBJU.2015.022527564286
  • Liu C, Zheng S, Li H, Xu K. Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol. 2010;184(6):2440–2445. doi:10.1016/j.juro.2010.08.03720952005
  • Sedrakyan A, Campbell B, Merino JG, et al. IDEAL-D: a rational framework for evaluating and regulating the use of medical devices. Bmj. 2016;353:i2372. doi:10.1136/bmj.i237227283585
  • Chen S, Zhu L, Cai J, et al. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol. 2014;66(2):284–291. doi:10.1016/j.eururo.2014.01.01024502959
  • Bang WJ, Kim HW, Lee JY, et al. Prostatic urethral angulation associated with urinary flow rate and urinary symptom scores in men with lower urinary tract symptoms. Urology. 2012;80(6):1333–1337. doi:10.1016/j.urology.2012.08.05823206777
  • Cho KS, Kim JH, Kim DJ, et al. Relationship between prostatic urethral angle and urinary flow rate: its implication in benign prostatic hyperplasia pathogenesis. Urology. 2008;71(5):858–862. doi:10.1016/j.urology.2008.01.01918343484
  • Homma Y, Kawabe K, Tsukamoto T, et al. Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol. 1996;3(4):267–273. doi:10.1111/iju.1996.3.issue-48844281
  • Demidenko E. Sample size determination for logistic regression revisited. Stat Med. 2007;26(18):3385–3397. doi:10.1002/sim.277117149799
  • van Smeden M, Moons KG, de Groot JA, et al. Sample size for binary logistic prediction models: beyond events per variable criteria. Stat Methods Med Res. 2019;28(8):2455–2474. doi:10.1177/096228021878472629966490
  • Lee LS, Sim HG, Lim KB, Wang D, Foo KT. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. Int J Urol. 2010;17(1):69–74. doi:10.1111/j.1442-2042.2009.02409.x19919641
  • Choi J, Ikeguchi EF, Lee SW, et al. Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index? Eur Urol. 2002;42(1):7–11. doi:10.1016/S0302-2838(02)00222-112121722
  • Cho KS, Kim J, Choi YD, Kim JH, Hong SJ. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation. Med Hypotheses. 2008;70(3):532–535. doi:10.1016/j.mehy.2007.07.01217761390
  • Dessombz A, Meria P, Bazin D, Daudon M. Prostatic stones: evidence of a specific chemistry related to infection and presence of bacterial imprints. PLoS One. 2012;7(12):e51691. doi:10.1371/journal.pone.005169123272143
  • Gandaglia G, Briganti A, Gontero P, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 2013;112(4):432–441. doi:10.1111/bju.2013.112.issue-423650937
  • Kim WB, Doo SW, Yang WJ, Song YS. Influence of prostatic calculi on lower urinary tract symptoms in middle-aged men. Urology. 2011;78(2):447–449. doi:10.1016/j.urology.2010.12.05621689847
  • Ficarra V. Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)? BJU Int. 2013;112(4):421–422. doi:10.1111/bju.2013.112.issue-423879899
  • Calleja R, Yassari R, Wilkinson EP, Webb R. Bladder outflow obstruction caused by prostatic calculi. Sci World J. 2004;4(Suppl 1):46–47. doi:10.1100/tsw.2004.45
  • Hyun JS. Clinical significance of prostatic calculi: a review. World J Mens Health. 2018;36(1):15–21. doi:10.5534/wjmh.1701829076299
  • Kim SH, Jung KI, Koh JS, et al. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi? Urol Int. 2013;90(2):144–149. doi:10.1159/00034264323295780
  • Park SW, Nam JK, Lee SD, Chung MK. Are prostatic calculi independent predictive factors of lower urinary tract symptoms? Asian J Androl. 2010;12(2):221–226. doi:10.1038/aja.2009.7519966831
  • Goyal NK, Goel A, Sankhwar S. Transurethral holmium-YAG laser lithotripsy for large symptomatic prostatic calculi: initial experience. Urolithiasis. 2013;41(4):355–359. doi:10.1007/s00240-013-0571-x23715770